Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 2, 2002, Pages 193-198

  Shu, Toshifusa ^a   Suzuki, Hideshi ^a   Hironaka, Kenji ^a   Ito, Kunio ^a  

^a Janssen Pharmaceutical KK   (Japan)

Author keywords

Co ground mixture; Crospovidone; D mannitol; Direct compression; Rapidly disintegrating tablets

Indexed keywords

ASCORBIC ACID; CARBOHYDRATE DERIVATIVE; CARBOXYMETHYLSTARCH SODIUM; CROSCARMELLOSE SODIUM; CROSPOVIDONE; ERYTHRITOL; HYDROXYPROPYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE; MANNITOL; NIFEDIPINE; STARCH; STARCH GLYCOLATE SODIUM; WATER; XYLITOL; POVIDONE;

ARTICLE; CHEMICAL PROCEDURES; COMPRESSION; DRUG SOLUBILITY; HARDNESS; MOUTH CAVITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; TABLET FORMULATION; CHEMISTRY; MOUTH; SOLUBILITY; TABLET;

MANNITOL; MOUTH; POVIDONE; SOLUBILITY; TABLETS;

EID: 0036482637     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.193     Document Type: Article

References (19)

1. Hanawa T., Pharm. Tech. Jpn., 13, 251-258 (1997).
2. Kimura T., Pharm. Tech. Jpn., 4, 577-584 (1988).
3. Sugihara M., Farumashia, 30, 1396-1400 (1994).
4. Sugihara M., Current Therapy, 8, 333-334 (1990).
5. Kearney P., Yarwood R. J., Pharm. Tech. Jpn., 9, 713-719 (1993).
6. Masaki K., The collected papers of the 22nd Conference on Pharmaceutical Technology, July 1997, pp. 79-84.
7. Tsushima Y., Farumashia, 33, 1119-1123 (1997).
8. Mizumoto T., Masuda Y., Fukui M., Ohmura T., The collected papers of the 15th Symposium on Particulate Preparations and Design, October 1998, pp. 165-167.
9. Makino T., Yamada M., Kikuta J., JP Patent Appl., 5-271054 (1993).
10. Tatara M., Matsunaga K., Shimizu T., JP Patent Appl., 8-291051 (1996).
11. Murakami T., Uchida S., Iki T., Aritomi H., Seki H., The collected papers of the 16th Symposium on Particulate Preparations and Design, October 1999, pp. 261-266.
12. Okumura M., Motegi S., Miyazaki K., Pharm. Tech. Jpn., 14, 367-373 (1998).
13. Bi Y., Sunada H., Yonezawa Y., Danjyo K., Otsuka A., Iida K., Chem. Pharm. Bull., 44, 2121-2127 (1996).
14. Bi Y., Sunada H., Pharm. Tech. Jpn., 14, 1723-1733 (1998).
15. International Specialty Products, "Polyplasdone® XL Polyplasdone® XL-10," ISP, New Jersey, U.S.A., pp. 3-5.
16. Bolhuis G. K., Van Kamp H. V., Lerk C. F., Arends J. W., en Stuut G. J., Acta Pharm. Technol., 30, 24-32 (1984).
17. Abdou H. M., Mack, "Dissolution, Bioavailability & Bioequivalence," Mark Publishing Company, Easton Pennsylvania, 1989, pp. 265-284.
18. Wikberg M., Alderborn G., Int. J. Pharmaceut., 69, 239-253 (1991).
19. Kubo H., Mizobe M., Biol. Pharm. Bull., 20, 460-463 (1997).